Replies to post #327889 on NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

To update the endpoints on this particular page would take someone even with limited knowledge no more than a couple of hours. Do you really think that they are so tied up that they could not do this simple task.
This inability to update a simple page with data that can be copied and pasted in, just serves to sow doubt which feeds the shorts. As Flipper has alluded are they still trying to ensnare their enemies which I doubt as they have so much more important tasks to achieve at this point.
Delivering stellar topline would be enough to crush any shorts that have targeted this company for all these years.
I agree with BSB that if the endpoints have been accepted by the FDA then NWBO owes it to to its shareholders to do the very simple task of updating the Clinical trials webpage.
Maybe Sentiment can request DI to personally oversee this very easy task which would in one swift moment support and grow the SP through to topline.
If NWBO refuse to do this task then we have to assume that the FDA has not agreed to the new endpoints.

[anders2211]

I do not believe that updating the clinical trial register right now is a top priority for NWBio. I think their primary focus now is TLD. But, I do believe NWBio will update the clinical trial register just before or just after the DCVax-L TLD is released.

I believe that too altnsider

for example, we know for a fact that the EU+UK are onboard. Has NWBO PRed that, no, other biotechs would have not NWBO. Does that make the buy-in of these regulators less valid, no of course not.